Clinical Trial Update: The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota [Phase 2]

View source ↗

Summary

Phase 2 trial investigating clindamycin and a live biotherapeutic for improving reproductive outcomes in IVF patients with abnormal vaginal microbiota.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis
• Infertility Female

Drugs mentioned

• Clindamycin
• live biotherapeutic

Snippet

Sponsor: Peter Humaidan | Conditions: Bacterial Vaginoses, Infertility, Female | Phase 2 | Status: UNKNOWN